Gyre Therapeutics, Inc. GYRE Q2 2025 earnings
Reported August 11, 2025 · Before market open
Revenue$26.8MMiss by $7.5M
EPS$0.02Miss by $0.01
Revenue estimate$34.3M
EPS estimate$0.03
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$26.5M
EPS estimate-$0.08
Financials
Q2 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Gyre Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Gyre Therapeutics, Inc. report Q2 2025 earnings?
- Gyre Therapeutics, Inc. (GYRE) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Gyre Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Gyre Therapeutics, Inc. reported revenue of $26.8M and eps of $0.02 for Q2 2025.
- Did Gyre Therapeutics, Inc. beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $34.3M by $7.5M. EPS missed the consensus estimate of $0.03 by $0.01.
- How did Gyre Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 6.1% from $25.2M a year earlier and eps grew 100.0% from $0.01.
- Where can I find Gyre Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-106644) directly on SEC EDGAR. The filing index links above go to sec.gov.